The reflective season of the year has begun, and we would like to take this opportunity to thank you for the trust you have placed in us. The Christmas season reminds us of the importance of safety and health—values that guide our daily work in medicine.
This year, we are therefore donating €10,000 to the Bundesverband Kinderhospiz e.V.
We greatly appreciate your loyalty and collaboration, and we wish you and your families a joyful Christmas and a successful start to the coming year.
The work of this association in support of seriously ill children and their families moves us deeply. As a pharmaceutical manufacturer in the field of nuclear medicine—especially in cancer diagnostics—we are acutely aware of our responsibility toward those who rely on help the most. As a company dedicated to the well-being of patients and the improvement of quality of life, it is important to us to have a positive impact on society beyond the field of medicine.
We firmly believe that public awareness of issues such as the care of seriously ill children should be strengthened to foster solidarity and compassion. With our donation, we hope to bring comfort and support to families during difficult times.
Ähnliche Beiträge
New CFO at ROTOP – Dr. Michael Peterseim
March 13, 2026 - We’re pleased to Welcome Dr. Michael Peterseim as our new Chief Financial Officer (CFO) at ROTOP. Dr. Peterseim brings many years of experience in financial leadership and has successfully guided companies through transformation processes, strengthened performance, and executed strategic transactions, particularly in growth situations.
ROTOP Pharmaka Welcomes State Minister Dirk Panter: Radiopharmacy as a Key Technology in Modern Cancer Care
January 9, 2026 - ROTOP Pharmaka welcomed Saxony’s State Minister Dirk Panter during the region’s Radiopharmacy Theme Day. The exchange highlighted the importance of modern radiopharmacy for cancer care as well as ROTOP’s contribution through diagnostics, ready to use patient doses, and CDMO services, with a particular focus on theranostic concepts.
ROTOP featured in VentureCapital Magazine
August 15, 2025 - We are delighted to be featured in the latest issue of VentureCapital Magazine, which spotlights the Dresden region as a high-performance hub for key players and innovators in radiopharmaceutical innovation. ROTOP Pharmaka is recognized as a leading manufacturer of radiopharmaceuticals, including an iodine-123 compound used in Parkinson’s diagnostics. The article also emphasizes the strong network we are part of – combining research collaborations, advanced manufacturing, and the development of innovative theranostic solutions.
